12:00 AM
 | 
May 04, 2015
 |  BC Week In Review  |  Clinical News  |  Regulatory

Micellular paclitaxel regulatory update

Russia approved Paclical micellular paclitaxel from Oasmia to treat epithelial ovarian cancer in combination with carboplatin. Oasmia said...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >